Terms: = Uterine cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
417 results:
1. Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
Bridge F; Brotherton J; Stankovich J; Sanfilippo PG; Skibina OG; Buzzard K; Kalincik T; Nguyen AL; Guo K; Monif M; Wrede CD; Rath L; Taylor L; Butzkueven H; Jokubaitis VG; Van Der Walt A
Neurology; 2024 Feb; 102(4):e208059. PubMed ID: 38306594
[TBL] [Abstract] [Full Text] [Related]
2. Long-term health-related quality-of-life and psychosocial outcomes after uterus transplantation: a 5-year follow-up of donors and recipients.
Järvholm S; Kättström A; Kvarnström N; Dahm-Kähler P; Brännström M
Hum Reprod; 2024 Feb; 39(2):374-381. PubMed ID: 37995381
[TBL] [Abstract] [Full Text] [Related]
3. Reducing health disparities in endometrial cancer care in 2024.
Stewart CE; Nañez A; Ayoola-Adeola M; Chase D
Curr Opin Obstet Gynecol; 2024 Feb; 36(1):18-22. PubMed ID: 37902961
[TBL] [Abstract] [Full Text] [Related]
4. Advances in the Management of Recurrent Cervical cancer: State of the Art and Future Perspectives.
Giudice E; Mirza MR; Lorusso D
Curr Oncol Rep; 2023 Nov; 25(11):1307-1326. PubMed ID: 37870697
[TBL] [Abstract] [Full Text] [Related]
5. Human Papillomavirus Detectability and Cervical cancer Prognosis: A Systematic Review and Meta-analysis.
Volesky-Avellaneda KD; Laurie C; Tsyruk-Romano O; El-Zein M; Franco EL
Obstet Gynecol; 2023 Nov; 142(5):1055-1067. PubMed ID: 37856917
[TBL] [Abstract] [Full Text] [Related]
6. Down-regulation of human papillomavirus E6 oncogene and antiproliferative effect of Schisandra chinensis and Pueraria lobata natural extracts on Hela cell line.
Cardona-Mendoza A; Fonseca-Benitez A; Buitrago DM; Coy-Barrera E; Perdomo SJ
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117225. PubMed ID: 37797877
[TBL] [Abstract] [Full Text] [Related]
7. Latest advances in immuno-oncology for endometrial cancer: single-agent and combination regimens.
Richardson M; Chase DM
Curr Opin Obstet Gynecol; 2024 Feb; 36(1):1-8. PubMed ID: 37792525
[TBL] [Abstract] [Full Text] [Related]
8. Disparities in Timeliness of Endometrial cancer Care: A Scoping Review.
Najor A; Melson V; Lyu J; Fadadu P; Bakkum-Gamez J; Sherman M; Kaunitz A; Connor A; Destephano C
Obstet Gynecol; 2023 Oct; 142(4):967-977. PubMed ID: 37734095
[TBL] [Abstract] [Full Text] [Related]
9. Systematic Review and Meta-analysis of laparoscopic radical hysterectomy vs. Robotic assisted radical hysterectomy for early stage cervical cancer.
Marchand G; Taher Masoud A; Abdelsattar A; King A; Brazil G; Ulibarri H; Parise J; Arroyo A; Coriell C; Goetz S; Moir C; Baruelo G; Govindan M
Eur J Obstet Gynecol Reprod Biol; 2023 Oct; 289():190-202. PubMed ID: 37690282
[TBL] [Abstract] [Full Text] [Related]
10. Oral gonadotrophin-releasing hormone (GnRH) antagonists: the continuing search for the ideal nonsurgical therapy of uterine fibroids with a cautionary tale.
Sim-Ifere O; Aref-Adib M; Odejinmi F
Curr Opin Obstet Gynecol; 2023 Oct; 35(5):460-465. PubMed ID: 37560806
[TBL] [Abstract] [Full Text] [Related]
11. Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus.
Chi Y; Shi L; Lu S; Cui H; Zha W; Shan L; Shen Y
J Ethnopharmacol; 2024 Jan; 318(Pt B):116969. PubMed ID: 37516391
[TBL] [Abstract] [Full Text] [Related]
12. Ovarian preservation in gynecologic oncology: current indications and techniques.
Bizzarri N; Pavone M; Loverro M; Querleu D; Fagotti A; Scambia G
Curr Opin Oncol; 2023 Sep; 35(5):401-411. PubMed ID: 37498120
[TBL] [Abstract] [Full Text] [Related]
13. New boundaries for fertility sparing management in endometrial cancer.
Rodolakis A; Pergialiotis V; Thomakos N
Curr Opin Oncol; 2023 Sep; 35(5):394-400. PubMed ID: 37498119
[TBL] [Abstract] [Full Text] [Related]
14. Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
Inayama Y; Takamatsu S; Hamanishi J; Mizuno K; Horinouchi N; Yamanoi K; Taki M; Murakami R; Yamaguchi K; Kosaka K; Efthimiou O; Kawakami K; Furukawa TA; Mandai M
Obstet Gynecol; 2023 Aug; 142(2):307-318. PubMed ID: 37411024
[TBL] [Abstract] [Full Text] [Related]
15. Naldemedine-induced opioid withdrawal with restlessness as the predominant symptom in a palliative care setting.
Sato R; Ishida M; Uchida N; Sakimoto T; Yamaguchi T; Ooya Y; Takahashi T; Onishi H
Palliat Support Care; 2023 Oct; 21(5):957-959. PubMed ID: 37350233
[TBL] [Abstract] [Full Text] [Related]
16. New treatment options for nonsurgical management of uterine fibroids.
Lee S; Stewart EA
Curr Opin Obstet Gynecol; 2023 Aug; 35(4):288-293. PubMed ID: 37144584
[TBL] [Abstract] [Full Text] [Related]
17. treatment options for molecular subtypes of endometrial cancer in 2023.
Karpel HC; Slomovitz B; Coleman RL; Pothuri B
Curr Opin Obstet Gynecol; 2023 Jun; 35(3):270-278. PubMed ID: 36943683
[TBL] [Abstract] [Full Text] [Related]
18. Risk of Recurrence and Reintervention After uterine-Sparing Interventions for Symptomatic Adenomyosis: A Systematic Review and Meta-Analysis.
Liu L; Tian H; Lin D; Zhao L; Wang H; Hao Y
Obstet Gynecol; 2023 Apr; 141(4):711-723. PubMed ID: 36897132
[TBL] [Abstract] [Full Text] [Related]
19. Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-κB pathway.
Yu YH; Zhang HJ; Yang F; Xu L; Liu H
J Ethnopharmacol; 2023 Jun; 310():116311. PubMed ID: 36894110
[TBL] [Abstract] [Full Text] [Related]
20. Sentinel lymphatic mapping for gynecologic malignancies.
Hari AY; Tewari KS
Curr Opin Obstet Gynecol; 2023 Feb; 35(1):43-53. PubMed ID: 36595648
[TBL] [Abstract] [Full Text] [Related]
[Next]
